In its annual “The Am Law 100” feature, The American Lawyer ranked Foley & Lardner 54th on its Am Law 100 list based on gross revenues. Am Law reported gross revenues last year for Foley of $686 million, a 10.5 percent increase over 2016, bumping the firm up one spot on the AmLaw 100 list.
The annual Am Law 100 feature analyzes the financial health of the nation’s 100 largest law firms by gross revenue and other key metrics based off of 2017 returns.
Using other metrics, The American Lawyer ranked Foley:
- 61st based on 2017 revenue per lawyer
- 64th based on 2017 profits per partner
- 54th based on 2017 gross revenue per lawyer
- 71st based on 2017 compensation to all partners
- 81st based on 2017 profits per lawyer
- 65th based on its 2017 profitability index
- 70th based on 2017 value per lawyer
For complete details, metrics and calculations, read “The 2018 Am Law 100.” (subscription required)
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”